Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00637169 · ClinicalTrials.gov registry record · Phase 3
Canadian Oxygen Trial (COT)
A Phase 3 study, sponsored by McMaster University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,201
- Enrollment target
NCT00637169 is a Phase 3 study that has completed, run by McMaster University. The registered enrollment target is 1,201 participants.
The verdict
NCT00637169, a Phase 3 study, has completed, sponsored by McMaster University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,201 participants
- Enrollment target
Study Summary
Study Question: In infants who are born at gestational ages of 23 0/7 to 27 6/7 weeks, does lowering the concentration of supplemental oxygen to target an arterial oxygen saturation by pulse oximetry (SpO2)of 85-89% compared with 91-95%, from the day of birth until the baby's first discharge home, increase the probability of survival without severe neurosensory disability to a corrected age of 18 months?
Interventions
- OTHER Titration of oxygen therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,201 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00637169
The ClinicalTrials.gov registry entry for NCT00637169 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McMaster University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Titration of oxygen therapy is the first listed.
NCT00637169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00637169 about?
NCT00637169 is a clinical study titled "Canadian Oxygen Trial (COT)". Study Question: In infants who are born at gestational ages of 23 0/7 to 27 6/7 weeks, does lowering the concentration of supplemental oxygen to target an arterial oxygen saturation by pulse oximetry (SpO2)of 85-89% compared with 91-95%, from the day of birth until the baby's first discharge home, i...
What is the current status of trial NCT00637169?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,201 participants. The study started on 2006-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00637169?
The interventions under investigation include: Titration of oxygen therapy (OTHER).
Who is sponsoring clinical trial NCT00637169?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.